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Clinicopathology of kidneys from brain-dead patients treated with
vasopressin and epinephrine. Studies were made on the biochemical and
pathological conditions of kidneys of 20 brain-dead patients who were
maintained for 0 to 48 days after brain death by administration of
vasopressin and epinephrine. Twenty specimens were obtained by
percutaneous biopsy or at autopsy. The biochemical and pathological
degrees were compared with those on the day of brain death (day 0).
Biochemical tests on day 0 indicated that they showed the diuretic
phase of prerenal failure, and then glomerular hyperemia was exten-
sive. Renal function recovered on day 1 and remained almost normal
during the 14 day period. Their urine retained high levels of sodium and
osmolarity for days 0 to 14, with mild hyponatremia and hypo-
osmolarity of the plasma. Tubulointerstitial nephritis gradually became
extensive. There was no significant change in the degrees of mesangial
widening, mesangial cell proliferation or hyalinosis. Arterial intimal
proliferation was gradually extensive after day 3 and glomerular endo-
thelial proliferation was gradually extensive after a week. Brain-dead
patients have been mostly reported to develop diabetes insipidus, but
our brain-dead patients did not show any manifestation of this disease.
We suggest that constant natriurisis and continuing high level of urine
osmolarity might have been caused by prerenal renal failure, brain
death followed by neurogenic impairment, high level of serum vaso-
pressin, or interstitial nephritis.
Brain-dead patients who have cerebral lesions, such as intra-
cranial hemorrhage, neoplasia or infection, usually develop
cardiac arrest within a few days. Recently, the prolonged
maintenance of these patients has been achieved by continuous
infusion of vasopressin with epinephrine [1]. We have reported
clinicopathological studies on the livers of brain-dead patients
after prolonged maintenance [2]. We observed that during
prolonged hemodynamic maintenance of brain-dead patients,
pathological lesions did not spread or diminished, and that
biochemical indices did not become worse, or improved, in the
first two weeks, except for increases in cholangitis and the
serum alkaline phosphatase level. These disorders may have
been caused by functional cholestasis due to dysfunction of the
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vagus after brain death. Here we made clinicopathological
study of kidneys from brain-dead patients.
Brain-dead patients have been reported by Howlett et alto
primarily develop clinical diabetes insipidus a few days after
brain death [3]; this disease has manifestations of polyuria,
urinal hypo-osmolarity, and normal sodium excretion [4]. Pa-
tients with intracranial disease also are reported to frequently
show the syndrome of inappropriate secretion of antidiuretic
hormone (SIADH) [5—71. In this syndrome, continued secretion
of antidiuretic hormone results in natriuresis, low level of serum
osmolarity and dilutional hyponatremia [8—10]. Cerebral dis-
eases may also result in cerebral salt-losing syndrome [11—161.
Most features of this syndrome are same as those of SIADH,
but this syndrome is usually accompanied with extracellular
volume depletion which is not usually found in SIADH [17, 18].
Originally, the primary defect of this syndrome is thought to be
the inability of the kidney to conserve sodium [17, 18].
Clinical renal data in brain-dead patients has been reported
by Kinoshita et al [19]. However, pathological renal data in
brain-dead patients have not been reported. We report investi-
gations on the clinicopathological changes of the kidneys of
brain-dead patients during prolonged hemodynamic mainte-
nance by administration of vasopressin and epinephrine.
The brain-dead patients were not kept alive simply for the
purpose of the study. In Japan, death is legally pronounced at
the point of cardiac arrest. Brain death per se is not a legal
determinant. Therefore, physicians are obligated to sustain life
despite brain death until cardiac arrest occurs. Accordingly,
these studies were conducted in acceptable ethical principles of
Japanese law.
Methods
Patients
Brain death was defined according to the criteria of the Brain
Death Study Group sponsored by the Ministry of Health and
Welfare, which requires all of the following criteria: deep coma,
apnea, lack of a brain-stem reflex, and a silent electroenceph-
alogram for over six hours. Details of the 20 brain-dead patients
examined in this study are given in Table 1. These 20 brain-dead
patients ranged from 22 to 70 years old. Their primary diseases
were as follows: head injury in 12, subarachnoidal hemorrhage
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Table 1. Data on brain-dead patients and times when kidney specimens were obtained
Patient Age Sex
Day of
cardiac
arrest Cause of brain death
Kidney
specimen
hoursa
1 22 Male 0 Malignant lymphoma Autopsy (1)
2 46 Female 0 Brain tumor Autopsy (1)
3 47 Male 0 Brain tumor Autopsy (1.5)
4 37 Female 0 Subarachnoidal hemorrhage Autopsy (10)
5 44 Male 0 Subarachnoidal hemorrhage Autopsy (7)
6 46 Male 3 Thoracoabdominal injury Autopsy (15)
7 58 Male 3 Head injury Autopsy (1.5)
8 33 Male 4 Head injury Necropsy
9 45 Male 7 Head injury Autopsy (4)
10 37 Male 9 Head injury Necropsy
11 50 Male 9 Head injury Necropsy
12 42 Male 10 Head injury Autopsy (11)
13 43 Female 12 Head injury Autopsy (2.5)
14 58 Female 12 Subarachnoidal hemorrhage Autopsy (14)
15 61 Female 13 Head injury Autopsy (14)
16 45 Male 15 Cyanide poisoning Autopsy (4)
17 29 Male 15 Head injury Autopsy (2)
18 70 Male 16 Head injury Autopsy (5.5)
19 43 Female 40 Head injury Autopsy (7)
20 22 Male 48 Head injury Autopsy (2)
Patients 1-5 received no mechanical ventilation or infusion of vasopressin. Patients 6 to 20 received vasopressin with epinephrine, and also
respiratory and fluid management. The day of brain death was defined as day 0.
a Hours between cardiac arrest and autopsy.
in three, brain tumor in two, malignant lymphoma in one,
cyanide poisoning in one, and thoracoabdominal injury in one.
Fifteen of the 20 brain-dead patients received vasopressin at a
constant rate of one or two units/hr (285 45 tU/kg/min) with
epinephrine (total amount: 34 to 984 mg) to maintain a systolic
blood pressure of more than 90 mm Hg. They also received
respiratory control and fluid management, with 2400 to 4800 ml
of fluid per day. The serum anti-diuretic hormone level in the
patients receiving vasopressin was 10 to 40 pg/mI (normal
range, 0.3 to 4.2 pg/mi). These procedures were carried out at
the Department of Traumatology, Osaka University Hospital.
The direct causes of cardiac arrest of the patients were heart
failure in two, pulmonary failure in two and renal failure in one,
and were unknown in 10. All 15 patients received antiulcerative
drugs, antibiotics, and various electrolyte solutions. They had
not received any irradiation therapy and had no episode of
immunological disorder. Of the other five patients, two were
examined at autopsy at the Tokyo Medical Examiner's Office,
two at Osaka Prefectural Hospital, and one at Osaka University
Medical School. These patients had not received mechanical
ventilation or infusion of vasopressin.
Biochemical tests on kidney function
We measured the urine volume, creatinine clearance, serum
creatinine, blood urea nitrogen, serum potassium, sodium in-
take, urinary sodium output, plasma osmolarity and urinary
osmolarity. The urine volume and creatinine clearance were
measured by collecting urine via a urethral catheter for 24
hours. Serum creatinine, blood urea nitrogen, serum potassium
and serum sodium were examined by standard methods with an
automated chemical analyzer. Sodium intake was calculated
based on the total volume of electrolyte solution given intrave-
nously, and urinary sodium output was calculated from the
urinary sodium level and urine volume. The osmolarities of
plasma and urine were measured with an osmometer.
The normal ranges of these parameters are as follows: urine
volume 600 to 1600 ml/day; creatinine clearance 60 to 145
mI/mm; serum creatinine level 0.9 to 1.6 mg/dl; blood urea
nitrogen level 9 to 20 mgldl; serum potassium level 3.5 to 5.0
mEq/liter; urinary sodium output 40 to 185 mEq/day; serum
sodium level 134 to 144 mEq/liter; and plasma osmolarity 285 to
295 mOsm/liter.
Pathological examination
Seventeen kidney specimens were obtained at autopsy and
three by percutaneous biopsy with a 15-gauge needle. The
specimens were fixed in 10% buffered formalin (pH 7.2), and
processed routinely for embedding in paraffin. Sections were
cut at 3 to 5 jm thickness, and stained with hematoxylin and
eosin, periodic acid Shiff reaction (PAS), periodic acid-methe-
namine silver stain (PAM), and Azan-Mallory stain.
The degrees of pathological lesions of the tubular lesions
(vacuolar degeneration, acidophilic degeneration, atrophy and
necrosis of the lining cells of the proximal or distal tubules),
interstitial scar, arterial intimal proliferation, and glomerular
lesions (glomerular hyperemia, glomerulitis, intracapillary en-
dothelial proliferation, mesangial widening, mesangial cell pro-
liferation, hyalinosis, periglomerular fibrosis, and periglomeru-
litis) were evaluated. Tubular vacuolar degeneration was
defined as vacuolated or vesicular degeneration of the tubular
lining cells in the cortex. Tubular acidophilic degeneration was
defined as the presence of tubular lining cells containing acido-
philic granules. Tubular atrophy was defined as a dilated
tubulus or flattened tubular epithelium. Tubular necrosis was
defined as pyknosis, karyolysis or karyorrhexis of tubular lining
cells. Distal tubules consisted of distal convoluted tubules and
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the cortical collecting duct. Interstitial scar was defined as a
fibrous lesion containing necrosed or destroyed tubules in the
cortex detected in sections stained by the Azan-Mallory
method. Arterial intimal proliferation was defined as intimal
edematous cellular thickening detected in sections stained by
the Azan-Mallory method. Glomerular hyperemia was defined
as the presence of segmental or global capillary loops com-
pacted with erythrocytes. Glomerulitis was defined as the
presence of five or more white blood cells such as lymphocytes,
neutrophils or monocytes in a glomerulus. Endothelial prolifer-
ation was defined as the presence of two or more endothelial
cells in more than one capillary loop of a glomerulus. Mesangial
cell proliferation was defined as the presence of four more
mesangial cells in a mesangium of a glomerulus [20]. Mesangial
widening and hyalinosis were evaluated by examining sections
stained with PAS, and periglomerular fibrosis was evaluated by
examining sections stained with Azan-Mallory stain. Penglom-
erulitis was defined as periglomerular lymphocytic infiltration.
The degrees of tubular lesions were evaluated as the numbers
of involved fields among 100 randomly selected high power
fields (x 400 fields). Interstitial scars were evaluated as mean
numbers of lesions in 100 glomerulo-cortical areas. The degree
of arterial intimal proliferation was evaluated as the percentage
of arteries involved; totals of 100 to 140 (mean SE; 114 3)
arteries in autopsy specimens and 11 to 29 (mean SE; 17 6)
arteries in necropsy specimens were examined. The degrees of
glomerular lesions were evaluated from the percentages of
glomeruli involved; totals of 104 to 701 (mean SE: 327 22)
glomeruli in autopsy specimens and 21 to 64 (mean SE: 33
6) glomeruli in necropsy specimens were examined.
Statistical evaluation
The significances of difference were evaluated by Student's
t-test.
Results
Bioche,nical findings
The time courses of changes in the mean urine volume,
creatinine clearance, serum creatinine, blood urea nitrogen,
sodium intake, urinary sodium output, serum sodium, plasma
osmolarity and urinary osmolarity are shown in Figures 1 and 2.
The urine volume was markedly above the upper normal range
on days 0 to 14. The mean value for creatinine clearance was
below the normal range on day 0, but improved, being within
the normal range on days 1 to 14. The mean values of serum
creatinine, blood urea nitrogen and serum potassium were
within almost normal ranges on days 0 to 14. However, the
mean value of serum potassium on day 1 decreased to below the
normal range and then increased slightly.
The mean urinary sodium output was markedly increased
throughout the 14-day period. Sodium intake significantly ex-
ceeded urinary sodium output on days 0 and 1, and then was
almost equal with the urinary sodium output. The mean values
of serum sodium and plasma osmolarity were above the normal
range on days 0 and 1, but then decreased gradually. The mean
urinary osmolarity was 523 to 622 mOsm/liter, and was above
the mean plasma osmolarity (270 to 316 mOsm/liter) throughout
the 14-day period.
3,000
1,500
110
90
60
40
11 11 12 8
0
Serum potassium *5
4
w
E 3
122 •01 3 5 7 10 14
Time, days after brain death
Fig. 1. Time courses of change in urine volume, creatinine clearance,
serum creatinine, blood urea nitrogen, and serum potassium of 15
brain-dead patients. All the patients received vasopressin at a constant
rate of 1 or 2 U/hr in conjunction with epinephrine to maintain their
systolic blood pressure at above 90 mm Hg. They also received
respiratory control and fluid management (2400—4800 ml of fluid/day).
The normal ranges of urine volume, creatinine clearance, serum creat-
mine, blood urea nitrogen and serum potassium are 600—1600 ml/day,
60—145 mI/mm, 0.9—1.6 mg/dl, 9—20 mgldl and 3.5—5.0 mEq/liter, respec-
tively. Points are means SE of values for the numbers of patients
shown below the points. * P < 0.05, vs. value on day 0. § mean value
above or below the normal range.
Pathological findings
Kidney specimens were divided into five groups depending
on the number of days after brain death on which they were
obtained: day 0, days 3 to 6, days 7 to 10, days 11 to 14, and
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Fig. 2. Time courses of change in sodium intake, urinary sodium
output, serum sodium level, plasma osmolarity and urinary osmolarity
of 15 brain-dead patients. Explanations of management of the patients
are as for Figure 1. The normal ranges of urinary sodium output, serum
sodium and plasma osmolanty are 40—186 mEq/day, 134—144 mEq/liter
and 285—295 mOsm/liter, respectively. Points are means SE of values
for the numbers of patients shown below the points. * P < 0.05, vs.
value on day 0. § mean value above or below the normal range. p <
0.05, vs. value of urinary sodium output.
days 15 to 48. The degrees of pathological lesions in these
groups were examined (Tables 2 and 3).
Degeneration of tubular lining cells, such as vacuolar degen-
eration, acidophilic degeneration, atrophy and necrosis, was
limited on day 0 (Fig. 3A), but increased on days 3 to 48. These
degenerative changes were more extensive in the distal tubuli
than in the proximal tubuli on days 0 to 48. Arterial intimal
proliferation was found in 7% of the arteries on day 0, but it
increased markedly on days 3 to 48, spreading to 42 to 85% of
the arteries.
Glomerular hyperemia was found in 92% of the glomeruli on
day 0 (Fig. 3B), but its incidence decreased gradually after day
3. This lesion was found in less than 10% of the glomeruli on
days 7 to 14 (Fig. 4). The degrees of glomerulitis, endothelial
proliferation and periglomerulitis did not change until day 6, but
increased slightly on days 7 to 48. There were no significant
changes in the degrees of mesangial widening, mesangial cell
proliferation, hyalinosis or interstitial scar in the 48-day period.
Periglomerular fibrosis and periglomerulitis were found in 16%
and 4%, respectively, of the glomeruli on day 0 (Fig. 3B).
However, these lesions increased gradually on days 3 to 14
(Fig. 4) and markedly on days 15 to 48, spreading to 92% and
65%, respectively, of the glomeruli (Fig. 5). There was no
purulent lesion of glomeruli or tubuli, which is usually found in
acute pyelonephritis.
Discussion
Brain-dead patients mostly develop clinical diabetes inspidus
after brain death [3j. In our brain-dead patients, urine volume
increased and creatinine clearance decreased on day 0. The
level of serum potassium fell on day 1. Creatinine clearance
improved on day 1 and remained within normal range for days
Ito 14. The levels of their serum sodium and plasma osmolarity
were above the normal ranges on days 0 and 1 when sodium
intake was markedly more than its output. These levels de-
creased after day 3, when the level of urinary sodium output
was almost the same as that of sodium intake. The levels of
urinary sodium output and urinary osmolarity remained at high
levels for days 0 to 14. These abnormalities are not symptoms of
diabetes insipidus [4]. The conditions of our patients are found
in obstructive nephropathy [211, adrenal insufficiency, renal
failure, SIADH, and the cerebral salt-losing syndrome [11—18].
Our patients showed no episode of urinary obstruction. They
probably had normal adrenal function, because the hypothala-
mus and pituitary of the brain-dead patients are reported to
maintain some functional activity, the level of cortisol being
within the normal range [22, 23]. We suspect that four processes
14 might have contributed to these conditions of our patients.
The first process might have been the diuretic phase of acute
prerenal renal failure [241. The large dose of sodium on day 0
may have been helpful to show a rapid recovery of renal
function, since increased ingestion of sodium chloride is re-
ported to protect against the impairment of renal function after
renal failure [25]. In the pathological examination, glomerular
hyperemia was extensive at day 0, but decreased markedly
thereafter. Degenerations were more extensive in the distal
tubules than in the proximal tubules from day 0. Glomerular
hyperemia is usually observed in circulatory disturbances such
as heart insufficiency, infarct and renal vein thrombus [26].
Epithelial cell necrosis of distal tubule is commonly found in
prerenal renal failure [24]. At the brain death (day 0), when
circulatory disturbance may occur, the blood pressure drops
rapidly, causing circulatory disturbances. Our patients after
brain death received infusion of vasopressin, infusion of fluid,
and respiratory control to maintain their blood pressure. Their
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Table 2. Degrees of tubular, interstitial and arterial lesions in the kidneys of brain-dead patientsa
Degree of pathological lesions %b
Day 0 Days 3—6 Days 7—10 Days 11—14 Days 15—48
Pathological lesions (N = 5) (N = 3) (N = 4) (N = 4) (N = 4)
Proximal tubuli; vacuolation 3 1 51 1" 47 15 66 170 61 200
acidophilic degeneration 1 0 11 20 10 10 15 5 23 2C
atrophy 0 0 5 20 4 1 1 0" 1 1
necrosis 4±2 5±5 14±8 16±5 28±50
Distal tubuli; vacuolation 8 2 57 60 34 9 83 90 67 15"
acidophilic degeneration 6 2 40 8"" 45 9"" 42 12 35 80
atrophy 0 0 29 le" 32 12 49 100(1 35 30
necrosis 17 4" 20 3 24 7 64 7"" 70 7"'
Interstitial scar 0 0 1 1 7 2 3 1 3 2
Arterial intimal proliferation 7 2 76 80 42 80 64 9" 85 50
a The kidney specimens were divided into 5 groups. The degrees of degeneration of the lining cells of the tubuli were evaluated as percentages
of lesions in the high-power fields examined. The degree of interstitial scar was evaluated as the mean number of lesions in 100 glomerulo-cortical
areas examined. The degree of arterial intimal proliferation were evaluated as the percentage of involved arteries.
b Data are mean SE
P< 0.05 vs. value on day 0 by Student's t-test
"p < 0.05 vs. the value for the same lesion in proximal tubuli
Table 3. Degrees of pathological glomerular lesions in the kidneys of brain-dead patientsa
Degree of pathological lesions (%)"
Day 0 Days 3—6 Days 7—10 Days 11—14 Days 15—48
Pathological lesion (N = 5) (N = 3) (N = 4) (N = 4) (N = 4)
Glomerular hyperemia 92 4 18 5" 8 2C 7 3" 32 80
Glomerulitis 3 1 6 2 12 IC 13 20 41 13
Endothelial proliferation 14 1 38 6 43 60 49 6C 67 30
Mesangial widening 7 2 3 0 11 3 8 2 13 4
Mesangial cell proliferation 1 0 3 2 3 1 3 1 3 1
Hyalinosis 0 0 1 1 4 2 1 0 4 4
Periglomerular fibrosis 16 4 43 5" 67 70 76 60 92 40
Periglomerulitis 4 2 6 1 27 60 35 70 65 I 1C
a The kidney specimens were divided into 5 groups. The degrees of glomerular hyperemia, glomerulitis, endothelial proliferation, mesangial
widening, mesangial cell proliferation, hyalinosis, penglomerular fibrosis, and periglomerulitis were evaluated as percentages of involved
glomeruli.
b Data are means SE
C P < 0.05 vs. value for group on day 0 by Student's t-test
rapid recovery may be caused by maintenance of the blood
pressure, and may also have been caused by a large dose of
sodium.
The second process might have been neurogenic impairment.
Brain death is defined as irreversible cessation of activity of the
brain, including the brain stem [27]. In this state the sympa-
thetic nervous system is dysfunctional since noradrenergic
neurons are restricted to the pontine and medullary segmental
regions, ramifying projections to the brain and spinal cord [28].
The renal cortex is under the control of its sympathetic fibers
[29], and renal sodium excretion is controled via sympathetic
nerves [30—34]. The renal sympathetic nerves are important for
rapid control of sodium excretion when sodium intake is altered
[321. Denervation of the peripheral renal sympathetic nerves is
reported to cause increase of urine flow and sodium excretion,
despite normal renal function [30, 34], and a central alpha-2-
adrenergic receptor antagonist is also reported to inhibit renal
sympathetic nerve activity and increase urinary sodium excre-
tion [34]. In our patients, although the sodium intake was in a
large dose on days 0 and 1, their urinary sodium output was not
reflected by the intake. This feature is also shown in the
"cerebral salt-losing syndrome" [14]. Thus, dysfunction of the
central sympathetic nervous system may have been one of the
causes of losing control of the serum sodium level of our
patients.
The third process might have been the high level of the serum
vasopressin. After brain death, our patients received vasopres-
sin continuously, and its level was maintained at above the
normal range. The high level of serum vasopressin causes
SIADH in which hyponatremia and hypo-osmolarity of the
serum, with normal renal function, are shown [8—10]. Thus,
continuous infusion of vasopressin may have caused gradual
hyponatremia and lower osmolarity of the plasma of our pa-
tients.
The fourth process might have been the pathological condi-
tion of the kidney. The major pathological changes of the
kidneys of our patients were changes of tubules, predominantly
distal tubules, soon after brain death. Then interstitial fibrosis
gradually became extensive, and two weeks after brain death,
extensive lymphocytic interstitial inflammation was also ob-
served. However, they scarcely had hyalinosis or interstitial
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FIg. 3. Histological features of tubuli and
glomeruli of the kidney from brain-dead
patients on day 0. (A) Acidophiic
degeneration and pyknotic nuclei were
observed focally in the lining cells of distal
tubuli in the kidney of Patient 2 in Table 1 on
the day of brain death (day 0). (H&E; x400),
(B) Glomerular hyperemia, observed globally
in the kidney of Patient 1 in Table I on the
day of brain death (day 0). (H&E; x200).
scars, which are usually found to increase in chronic pyelone-
phritis [35]. These findings conform well with those in tubu-
lointerstitial nephritis [35, 36]. Glomerulitis, which is often
found in tubulointerstitial nephritis [35], was extensive after day
15. There are reports that the kidneys show the pathological
features of interstitial nephritis in patients with hyponatremia
and salt loss [37, 38]. Mild hyponatremia and the constantly
high level of urinary sodium output may have been concerned
with tubulointerstitial nephritis. The kidneys in the diuretic
phase of acute renal failure may show tubulointestitial nephritis
[24]. Our patients showed this phase. Other causes may have
been also thought to be hypokalemia, irradiation, immunologic
reaction, drugs [36, 39, 40], and ischemia [41]. Our patients had
not received irradiation. They had not had the feature of
hypokalemia after day 2 nor immunologic reaction. They re-
ceived various antiulcerative drugs (cimetidine, ranitidine hy-
drochloride and secretin) and various antibiotics (cefametasole
sodium, ribostamycin sulphate, ampidillin, piperacillin sodium,
cefalotin sodium, fosfomycin, latamoxef sodium, sulbeniciffin
sodium and amikacin sulphate) until cardiac arrest after brain
death. Except for secretin these drugs have possibility of being
nephrotoxic [42]. Our patients had received mechanical venti-
lation after brain death, so that they might have been in
ischemia. Thus the administration of these various drugs or
ischemia, as well as the diuretic phase of acute renal failure,
might have caused tubulointerstitial nephritis in the present
brain-dead patients.
Arterial intimal proliferation was observed extensive after
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Fig. 4. Histological features of the
glomerulus of the kidney from Patient 13 in
Table 1 on day 12 after brain death. There is
no evidence of glomerular hyperemia, but
mild periglomerular fibrosis is seen. (H&E;
x 200).
Fig. 5. Histological features of the
periglomerular interstinum of the kidney of
Patient 18 on day 16 after brain death.
Lymphocytic infiltration in the periglomerular
and peritubular interstinum, periglomerular
fibrosis, and necrosis of the lining cells of
tubuli are marked. (Azan-Mallory stain;
xlOO).
day 3. This intimal proliferation is found in the chronic stage of
interstitial nephritis as adaptive hypertensive vasculopathy
[361, but the present patients were not hypertensive. However,
repeated administration of epinephrine causes arterial intimal
proliferation [43], and as our patients were given epinephrine
repeatedly to increase their blood pressure, this may have
caused extensive arterial intimal proliferation.
Glomerular endothelial proliferation of our patients increased
gradually after day 7. The glomerular endothelial proliferation is
thought to be observed in the kidney with overload [44]. Our
patients received large infusions and their urine volume were
relatively great. Thus they may have been in the state of fluid
overload.
Our brain-dead patients, after rapid recovery from prerenal
failure at brain death, kept a high level of the sodium output and
urinary osmolarity, with mild hyponatremia and hypo-osmolar-
ity of plasma. We suggest that their conditions might have been
caused by prerenal renal failure, brain death in itself, a high
level of serum vasopressin or interstitial nephritis.
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